# Mirna Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/mirna-therapeutics

- Industry: Pharmaceuticals
- Headquarters: Austin, US
- Website: www.mirnatherapeutics.com
- Total disclosed funding: $78M
- Latest round: Series D (May 1, 2015)
- Investors on record: 12

## About

Founded in 2007 and based in Texas, US, Mirna Therapeutics, Inc. is a biopharmaceutical company that develops microRNA-based therapeutics for the treatment of liver cancer and hematological malignancies. In April 2015, Baxter Ventures led a USD 41.8 million Series D financing for Mirna Therapeutics with participation from Eastern Capital, Santé Ventures, Morningside Ventures, Rock Springs Capital, and Celgene Corporation. The company became public in 2015 raising USD 43.8 million, and in May 2017, it merged with Synlogic, Inc.

## Funding rounds

- Series D, May 1, 2015, $42M — New Enterprise Associates, Sofinnova Investments, OUP (Osage University Partners), Correlation Ventures, 5Y Capital, Sante Ventures, Pfizer Venture Investments, Baxter Ventures, Rock Springs Capital, Eastern Capital Limited, Bristol-Myers Squibb Company
- Series C, Oct 24, 2012, $35M — New Enterprise Associates, Sofinnova Investments, OUP (Osage University Partners), Correlation Ventures, Pfizer Venture Investments
- Series B, Aug 23, 2011, $1.5M — PTV Healthcare Capital

## Investors

- PTV Healthcare Capital (https://capitalatlas.ai/funds/ptv-healthcare-capital) — Series B
- New Enterprise Associates (https://capitalatlas.ai/funds/new-enterprise-associates) — Series C, Series D
- Sofinnova Investments (https://capitalatlas.ai/funds/sofinnova-investments) — Series C, Series D
- OUP (Osage University Partners) (https://capitalatlas.ai/funds/oup-osage-university-partners) — Series C, Series D
- Correlation Ventures (https://capitalatlas.ai/funds/correlation-ventures) — Series C, Series D
- Pfizer Venture Investments (https://capitalatlas.ai/funds/pfizer-venture-investments) — Series C, Series D
- 5Y Capital (https://capitalatlas.ai/funds/5y-capital) — Series D
- Sante Ventures (https://capitalatlas.ai/funds/sante-ventures) — Series D
- Baxter Ventures (https://capitalatlas.ai/funds/baxter-ventures) — Series D
- Rock Springs Capital — Series D
- Eastern Capital Limited — Series D
- Bristol-Myers Squibb Company — Series D